Last reviewed · How we verify
Staphylococcal meningitis
Approved treatments
- Nallpen In Plastic Container · Pfizer
- Nallpen In Plastic Container · Pfizer
- Methocillin S · GSK
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - Zinacef · GSK
Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Rocephin · Generic (originally Roche)
- Bactocill In Plastic Container · Apothecon
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcal meningitis patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcal meningitis treatment landscape brief
- Staphylococcal meningitis treatment updates RSS
Frequently asked questions about Staphylococcal meningitis
What drugs treat Staphylococcal meningitis?
Tracked treatments include Nallpen In Plastic Container, Methocillin S, Ceftriaxon, Arikayce Kit, Zinacef, Rocephin, Bactocill In Plastic Container.
What is the treatment for Staphylococcal meningitis?
Standard treatment for Staphylococcal meningitis includes Nallpen In Plastic Container, Methocillin S, Ceftriaxon, Arikayce Kit, Zinacef. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcal meningitis patent cliff · Staphylococcal meningitis CI report
- Treatment: Nallpen In Plastic Container · Pfizer
- Treatment: Nallpen In Plastic Container · Pfizer
- Treatment: Methocillin S · GSK
- Treatment: Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Treatment: Arikayce Kit · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing